PRDM16 and acute kidney injury: Furthermore, we observe that formononetin may attenuate the progression of I/R‐ and cisplatin‐triggered AKI by regulating the PRDM16/S100A6/PKC‐η/ROS/p38MAPK and JNK signaling pathways.